Therapeutic targets in focal and segmental glomerulosclerosis

Current Opinion in Nephrology and Hypertension

Volumn 17, Issue 4, 2008, Pages 386-392

  Lavin, Peter J ^a   Gbadegesin, Rasheed ^a   Damodaran, Tirupapuliyur V ^a   Winn, Michelle P ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cell cycle; Glomerular basement membrane; Glomerular endothelial cells; Podocyte; Slit diaphragm

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA INTERFERON; CORTICOSTEROID; ERYTHROPOIETIN; NEPHRIN; PODOCALYXIN; PODOCIN; PODOPLANIN; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE; SLIT PROTEIN; ACTIN;

ACTIN POLYMERIZATION; CELL CYCLE; CELL DAMAGE; CELL PROTECTION; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GLOMERULUS BASEMENT MEMBRANE; KIDNEY INJURY; NONHUMAN; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEINURIA; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; ANIMAL; CELL MEMBRANE; CYTOSKELETON; GLOMERULUS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ACTINS; ANIMALS; CELL MEMBRANE; CYTOSKELETON; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; PODOCYTES; PROTEINURIA;

EID: 55249115801     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32830464f4     Document Type: Review

References (48)

1. Haas M, Spargo BH, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 1995; 26:740-750.
2. Barakat AJ, Arianas P, GlickAD, et al. Focal sclerosing glomerulonephritis in a child with Laurence-Moon-Biedl syndrome. Child Nephrol Urol 1990; 10:109-111.
3. Hara M, Ichida F, Higuchi A, et al. Nephropathy associated with Charcot-Marie-Tooth disease. Int J Pediatr Nephrol 1984; 5:99-102.
4. Ballermann BJ, Stan RV. Resolved: capillary endothelium is a major contributor to the glomerular filtration barrier. J Am Soc Nephrol 2007; 18:2432-2438.
5. Shankland SJ, Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000; 278:F515-F529.
6. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69:2131-2147.
7. Kestila M, Lenkkeri U, Mannikko M, et al. Positionally cloned gene for a novel glomerular protein - Nephrin is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1:575-582.
8. Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24:349-354.
9. Donoviel DB, Freed DD, Vogel H, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 2001; 21:4829-4836.
10. Verma R, Kovari I, Soofi A, et al. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116:1346-1359.
11. Jones N, Blasutig IM, Eremina V, et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006; 440:818-823.
12. Garg P, Verma R, Nihalani D, et al. Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol Cell Biol 2007; 27:8698-8712.
13. Winn MP, Conlon PJ, Lynn KL, et al. A mutation in theTRPC6 cation channel • causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801-1804.
14. Wei C, Moller CC, Altintas MM, et al. Modification of kidney barrier function by • the urokinase receptor. Nat Med 2008; 14:55-63. This study showed that upregulation of the urokinase receptor results in proteinuria and podocyte effacement through activation of αvβ3 integrin. Blockade of the αvβ3 integrin by specific inhibitors reduced proteinuria.
15. Yanagida-Asanuma E, Asanuma K, Kim K, et al. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am J Pathol 2007; 171:415-427.
16. SeverS, Altintas MM, Nankoe SR, et al. Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest 2007; 117:2095-2104.
17. GaleanoB, KlootwijkR, Manoli I, et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 2007; 117:1585-1594.
18. Hinkes B, Wiggins RC, Gbadegesin R, et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006; 38:1397-1405.
19. Garg P, Verma R, Holzman LB. Slit diaphragm junctional complex and regulation of the cytoskeleton. Nephron Exp Nephrol 2007; 106:e67-e72.
20. Mukerji N, Damodaran TV, Winn MP. TRPC6 and FSGS: the latest TRP channelopathy. Biochim Biophys Acta 2007; 1772:859-868.
21. Huber TB, Kwoh C, Wu H, et al. Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 2006; 116:1337-1345.
22. Reiser J, Polu KR, Moller CC, et al. TRPC6 is a glomerular slit diaphragmassociated channel required for normal renal function. Nat Genet 2005; 37:739-744.
23. Moller CC, Wei C, Altintas MM, et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 2007; 18:29-36.
24. Asanuma K, Yanagida-Asanuma E, Faul C, et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signaling. Nat Cell Biol 2006; 8:485-491.
25. KuriharaH, Anderson JM,KerjaschkiD, et al. The altered glomerularfiltration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1.Am J Pathol 1992; 141:805-816.
26. KojimaK, Davidovits A, Poczewski H, et al. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycanmatrix interaction. J Am Soc Nephrol 2004; 15:2079-2089.
27. Petermann AT, Krofft R, Blonski M, et al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 2003; 64:1222-1231.
28. Petermann AT, Pippin J, Krofft R, et al. Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol 2004; 98:e114-e123.
29. Vogelmann SU, Nelson WJ, Myers BD, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285:F40-F48.
30. Camici M. Urinary detection of podocyte injury. Biomed Pharmacother 2007; 61:245-249.
31. Kim YH, Goyal M, Kurnit D, et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60:957-968.
32. Griffin SV, Olivier JP, Pippin JW, et al. Cyclin I protects podocytes from apoptosis. J Biol Chem 2006; 281:28048-28057.
33. Wada T, Pippin JW, Marshall CB, et al. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: Role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 2005; 16:2615-2625.
34. Echigoya MH, Obikane K, Nakashima T, et al. Glomerular localization of erythropoietin receptor mRNA and protein in neonatal and mature mouse kidney. Nephron Exp Nephrol 2005; 100:e21-e29.
35. Logar CM, Brinkkoetter PT, Krofft RD, et al. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo. Kidney Int 2007; 72:489-498.
36. Griffin SV, Petermann AT, Durvasula RV, et al. Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins. Nephrol Dial Transplant 2003; 18 (Suppl 6):vi8-vi13.
37. Gherardi D, D'Agati V, ChuTH, et al. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 2004; 15:1212-1222.
38. Griffin SV, Krofft RD, Pippin JW, et al. Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis. Kidney Int 2005; 67:977-986.
39. Liebau MC, Lang D,BohmJ,et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006; 290:F710-F719.
40. Velez JC, Bland AM, Arthur JM, et al. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293:F398-F407.
41. Hiramatsu N, Hiromura K, Shigehara T, et al. Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J Am Soc Nephrol 2007; 18:515-527.
42. Smeets B, Te Loeke NA, Dijkman HB, et al. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 2004; 15:928-939.
43. Jarad G, Cunningham J, Shaw AS, et al. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006; 116:2272-2279.
44. Zenker M, Aigner T, Wendler O, et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004; 13:2625-2632.
45. Smithies O. Why the kidney glomerulus does not clog: a gel permeation/ diffusion hypothesis of renal function. Proc Natl Acad Sci USA 2003; 100: 4108-4113.
46. Karumanchi SA, Maynard SE, Stillman IE, et al. Preeclampsia: a renal perspective. Kidney Int 2005; 67:2101-2113.
47. Besbas N, Karpman D, Landau D, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006; 70:423-431.
48. Satchell SC, Buchatska O, Khan SB, et al. Interferon-beta reduces protenuria in experimental glomerulonephritis. J Am Soc Nephrol 2007; 18: 2875-2884.